Below are the financial statements of Sanofi, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of EUR | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net sales | 41.08a | 37.82a | 37.65a |
| Other revenues | 3.21a | 3.8a | 2.91a |
| Cost of sales | -13.21a | -12.63a | -11.88a |
| Gross profit | 31.08a | 28.99a | 28.68a |
| Research and development expenses | -7.39a | -6.51a | -6.5a |
| Selling and general expenses | -9.18a | -8.93a | -8.74a |
| Other operating income | 1.09a | 0.98a | 1.81a |
| Other operating expenses | -4.38a | -3.44a | -2.52a |
| Amortization of intangible assets | -1.75a | -1.91a | -1.8a |
| Impairment of intangible assets | -0.25a | -0.9a | -0.43a |
| Fair value remeasurement of contingent consideration | -0.1a | -0.09a | 0.03a |
| Restructuring costs and similar items | -1.4a | -1.03a | -1.08a |
| Other gains and losses, and litigation | -0.47a | -0.2a | -0.14a |
| Operating income | 7.25a | 6.96a | 10.16a |
| Financial expenses | -1.07a | -1.29a | -0.43a |
| Financial income | 0.52a | 0.58a | 0.21a |
| Income before tax and investments accounted for using the equity method | 6.7a | 6.25a | 9.94a |
| Income tax expense | -1.2a | -1.02a | -1.91a |
| Share of profit/(loss) from investments accounted for using the equity method | 0.06a | -0.14a | 0.06a |
| Net income from continuing operations | 5.55a | 5.1a | 8.08a |
| Net income from discontinued operations | 0.06a | 0.34a | 0.4a |
| Net income | 5.62a | 5.44a | 8.48a |
| Net income attributable to non-controlling interests | 0.06a | 0.04a | 0.11a |
| Net income attributable to equity holders of Sanofi | 5.56a | 5.4a | 8.37a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.